Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2021 07:10 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study

SAN DIEGO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of...
December 02, 2019 10:14 ET | Source: Reports and Data

Endocrine Testing Market To Reach USD 15.09 Billion By 2026 | Reports And Data

New York, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Increasing incidence of diabetes, thyroid, sedentary lifestyle, increasing government support, growing healthcare awareness and obesity are key factors...
October 03, 2018 08:00 ET | Source: Earth Science Tech, Inc.

Earth Science Tech, Inc. (ETST) Issues Update on CBD Patents and Reacts to DEA’s Shift on CBD

DORAL, Florida, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and...
September 27, 2018 08:00 ET | Source: Earth Science Tech, Inc.

Earth Science Tech, Inc. (ETST) Receives Updated Coverage and $3.60 Price Target from SeeThruEquity

DORAL, Florida, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and...
February 07, 2013 16:23 ET | Source: Relora(R)

Relora(R) Included as Part of Flat Belly Plan

SALINAS, Calif., Feb. 7, 2013 (GLOBE NEWSWIRE) -- The nation's leading health and wellness television program has, for the second time, featured Relora and its importance in the fight against belly...